Trial site
South Texas Accelerated Research Therapeutics (START) Midwest
- 7running trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer5 trials
- Lung cancer5 trials
- Pancreatic cancer4 trials
- Endometrial cancer2 trials
- Liver and biliary tract cancer2 trials
- Ovarian cancer2 trials
- Triple-negative breast cancer2 trials
- Brain metastases1 trial
- Cervical cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Gastric and oesophageal cancer1 trial
- Neuroendocrine tumours1 trial
- and 2 more
- Phase
- Phase 15 trials
- Phase 1/22 trials
- Status
- Recruiting4 trials
- Active, not recruiting3 trials
- Lead sponsor
- Eli Lilly and Company3 trials
- Institut de Recherches Internationales Servier1 trial
- MacroGenics1 trial
- Monte Rosa Therapeutics, Inc1 trial
- NiKang Therapeutics, Inc.1 trial
Running trials
Recruiting
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Recruiting
A Study of MGC028 in Participants With Advanced Solid Tumors
Active, not recruiting
A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Active, not recruiting
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Recruiting
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Recruiting
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer3 recruiting
- Lung cancer2 recruiting
- Pancreatic cancer2 recruiting
- Triple-negative breast cancer2 recruiting
- Brain metastases1 recruiting
- Cervical cancer1 recruiting
- Endometrial cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Ovarian cancer1 recruiting
- Thyroid cancer1 recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026